Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells.

The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S-conjugate S-(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1-transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance.

[1]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[2]  F. Baas,et al.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Scheper,et al.  Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. , 1995, British Journal of Cancer.

[4]  M. Saxena,et al.  ATP-dependent Efflux of 2,4-Dinitrophenyl-S-glutathione , 1995, The Journal of Biological Chemistry.

[5]  V. Gekeler,et al.  The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. , 1995, Biochemical and biophysical research communications.

[6]  P. Borst,et al.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[8]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[9]  D. Keppler,et al.  ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. , 1994, Cancer research.

[10]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Meijer,et al.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. , 1994, Cancer research.

[12]  I. Mellman,et al.  Mechanisms of cell polarity: sorting and transport in epithelial cells. , 1994, Current opinion in cell biology.

[13]  P. Sonneveld,et al.  Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. , 1994, Leukemia.

[14]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[15]  K. Ullrich.  Specificity of transporters for 'organic anions' and 'organic cations' in the kidney. , 1994, Biochimica et biophysica acta.

[16]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[17]  G. Rudenko,et al.  N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.

[18]  M. Caplan,et al.  An ion-transporting ATPase encodes multiple apical localization signals , 1993, The Journal of cell biology.

[19]  P. Jansen,et al.  Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells). , 1993, The Biochemical journal.

[20]  R Hori,et al.  Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.

[21]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[22]  T. Ishikawa,et al.  The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.

[23]  P. Borst,et al.  Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.

[24]  P. Jansen,et al.  Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. , 1989, The Journal of clinical investigation.

[25]  F. Di Virgilio,et al.  Inhibitors of membrane transport system for organic anions block fura-2 excretion from PC12 and N2A cells. , 1988, The Biochemical journal.

[26]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Dayton,et al.  Clinical Pharmacokinetics of Probenecid , 1981, Clinical pharmacokinetics.

[28]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[29]  Alfred Gilman,et al.  The Pharmacological Basis of Therapeutics , 1966 .

[30]  D. Hipfner,et al.  Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in Drug-selected and Transfected Human Tumor Cells , 1995 .

[31]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[32]  E. Rodriguez-Boulan,et al.  Polarity of epithelial and neuronal cells. , 1992, Annual review of cell biology.

[33]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Trump,et al.  2 The Kidney , 1969 .